TherapeuticsMD
TXMD
#10499
Rank
โ‚ฌ20.96 M
Marketcap
1,81ย โ‚ฌ
Share price
0.00%
Change (1 day)
86.56%
Change (1 year)

Operating Margin for TherapeuticsMD (TXMD)

Operating Margin as of July 2026 (TTM): 3.51%

According to TherapeuticsMD's latest financial reports and stock price the company's current Operating Margin is 3.51%. At the end of 2025 the company had an Operating Margin of -139.44%.

Operating Margin history for TherapeuticsMD from 2001 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-139.44%-49.31%
2024-275.07%-57.98%
2023-654.61%-4395.07%
202215.24%-100.49%
2021-3,092.77%1174.07%
2020-242.75%-24.5%
2019-321.51%-59.54%
2018-794.68%73.32%
2017-458.50%-1.25%
2016-464.32%9.79%
2015-422.93%17.78%
2014-359.09%22.38%
2013-293.42%-66.27%
2012-869.95%41.38%
2011-615.32%166.5%
2010-230.89%-98.52%
2009-15,570.87%
2006-13.45%-134.03%
200539.52%24.91%
200431.64%-20.19%
200339.64%13.74%
200234.85%18.94%
200129.30%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01% 242.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
9.51% 170.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-69.66%-2,084.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
69.45% 1,878.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-43.36%-1,335.33%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.